Transcriptomics

Dataset Information

0

EZH2-mediated epigenetic suppression of IFNa/b-STAT2 signaling enhances anti-tumor immunity in breast cancer

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Mus musculus Homo sapiens

PROVIDER: GSE183459 | GEO | 2022/12/28

REPOSITORIES: GEO

Json Xml

Similar Datasets

Transcriptomics EZH2-mediated epigenetic suppression of IFNa/b-STAT2 signaling enhances anti-tumor immunity in breast cancer [RNA-Seq]
2022-12-28 | GSE183458 | GEO
Genomics EZH2-mediated epigenetic suppression of IFNa/b-STAT2 signaling enhances anti-tumor immunity in breast cancer [ChIP-Seq]
2022-12-28 | GSE183457 | GEO
Unknown Epigenetic regulation of cancer biology and anti-tumor immunity by EZH2.
| S-EPMC5356764 | biostudies-literature
Unknown STAT2 is an essential adaptor in USP18-mediated suppression of type I interferon signaling.
| S-EPMC5365074 | biostudies-literature
Transcriptomics BET Inhibition Enhances TNF Mediated Anti-Tumor Immunity
2021-09-24 | GSE184592 | GEO
Unknown P38?/JNK signaling restrains erythropoiesis by suppressing Ezh2-mediated epigenetic silencing of Bim.
| S-EPMC6115418 | biostudies-literature
Unknown Dinaciclib induces immunogenic cell death and enhances anti-PD1-mediated tumor suppression.
| S-EPMC5785250 | biostudies-literature
Unknown Targeting EZH2 Enhances Antigen Presentation, Antitumor Immunity, and Circumvents Anti-PD-1 Resistance in Head and Neck Cancer.
| S-EPMC6942613 | biostudies-literature
Transcriptomics Epigenetic priming enhances anti-tumor immunity in resistant ovarian cancer
2022-06-20 | GSE188250 | GEO
Transcriptomics BET Inhibition Enhances TNF Mediated Anti-Tumor Immunity [RNA-Seq]
2021-09-24 | GSE184589 | GEO